Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin M Balko

Showing results (1-10 of 174) with videos related to

Pageof 18
Sort By:
Cancer Cell|April 14, 2023
No rest for the wicked: Tumor cell senescence reshapes the immune microenvironmentAnn Hanna, Justin M Balko
Breast Cancer Research and Treatment|July 29, 2021
Breast cancer resistance mechanisms: challenges to immunotherapyAnn Hanna, Justin M Balko
Breast Cancer Research and Treatment|August 10, 2010
Dead-box or black-box: is DDX1 a potential biomarker in breast cancer?Justin M Balko, Carlos L Arteaga
Cancer Discovery|February 13, 2018
A Critical Need for Better Cancer Immunotherapy Models: Are Organotypic Tumor Spheroid Cultures the Answer?Justin M Balko, Jeffrey A Sosman
Molecular Diagnosis & Therapy|February 21, 2012
Molecular signatures of lung cancer: defining new diagnostic and therapeutic paradigmsJustin M Balko, Carlos L Arteaga
Current Breast Cancer Reports|December 14, 2020
Biomarker predictors for immunotherapy benefit in breast: beyond PD-L1Jamaal L James, Justin M Balko
Biomarkers in Medicine|January 18, 2018
Biomarkers for assessing the effectiveness of immunotherapy in breast cancerMellissa J Nixon, Justin M Balko
Med (New York, N.Y.)|May 19, 2022
Primed for toxicity: CD4+ T cells and immune checkpoint inhibitorsDouglas B Johnson, Justin M Balko
Cancer Biology & Therapy|January 26, 2011
Do the genes tell us the path of most resistance?Justin M Balko, Ester P Black
Cancer Cell|March 3, 2023
T cell dynamism and immune-related adverse eventsDouglas B Johnson, Justin M Balko
Pageof 18

Showing results (1-10 of 174) with videos related to

Sort By:
Pageof 18
Cancer Cell|April 14, 2023
No rest for the wicked: Tumor cell senescence reshapes the immune microenvironmentAnn Hanna, Justin M Balko
Breast Cancer Research and Treatment|July 29, 2021
Breast cancer resistance mechanisms: challenges to immunotherapyAnn Hanna, Justin M Balko
Breast Cancer Research and Treatment|August 10, 2010
Dead-box or black-box: is DDX1 a potential biomarker in breast cancer?Justin M Balko, Carlos L Arteaga
Cancer Discovery|February 13, 2018
A Critical Need for Better Cancer Immunotherapy Models: Are Organotypic Tumor Spheroid Cultures the Answer?Justin M Balko, Jeffrey A Sosman
Molecular Diagnosis & Therapy|February 21, 2012
Molecular signatures of lung cancer: defining new diagnostic and therapeutic paradigmsJustin M Balko, Carlos L Arteaga
Current Breast Cancer Reports|December 14, 2020
Biomarker predictors for immunotherapy benefit in breast: beyond PD-L1Jamaal L James, Justin M Balko
Biomarkers in Medicine|January 18, 2018
Biomarkers for assessing the effectiveness of immunotherapy in breast cancerMellissa J Nixon, Justin M Balko
Med (New York, N.Y.)|May 19, 2022
Primed for toxicity: CD4+ T cells and immune checkpoint inhibitorsDouglas B Johnson, Justin M Balko
Cancer Biology & Therapy|January 26, 2011
Do the genes tell us the path of most resistance?Justin M Balko, Ester P Black
Cancer Cell|March 3, 2023
T cell dynamism and immune-related adverse eventsDouglas B Johnson, Justin M Balko
Pageof 18